Product Reports Resources Pricing Login Book a demo

CathVision

Health Tech & Medtech · Copenhagen, Denmark · Founded 2010

Ablation therapy of cardiac arrhythmia with novel hardware, software and data science MoreLess

CathVision is a pioneering startup focused on advancing the field of cardiac electrophysiology, specifically targeting the treatment of cardiac arrhythmias. The company is dedicated to empowering electrophysiologists—specialists who study and treat the electrical activities of the heart—to more effectively diagnose and cure arrhythmias. Cardiac arrhythmias, such as atrial fibrillation, affect approximately 20 million people globally and are associated with severe health issues like strokes and heart failure.

CathVision operates in the medical technology market, particularly within the niche of interventional electrophysiology. The company's flagship product, the CathVision Cube, is designed to record high-quality intracardiac electrograms. These are electrical signals from within the heart that help doctors distinguish between true clinical signals and artifacts (false signals). This differentiation is crucial for the success of procedures like ablation, a treatment that aims to cure arrhythmias by destroying the tissue causing the irregular heartbeat.

The business model of CathVision revolves around developing and providing cutting-edge medical devices to hospitals and clinics. Currently, their product is in the investigational stage, meaning it is being tested and is not yet available for commercial sale. The company is actively seeking partnerships with hospitals for a limited market release to further evaluate their product's effectiveness.

CathVision generates revenue through funding and grants, notably from the European Union's Horizon 2020 research and innovation program. This funding supports the development and testing of their medical devices. Once the product is commercially available, the company will likely generate income through direct sales to hospitals and clinics, as well as potential licensing agreements.

In summary, CathVision is a medical technology startup focused on improving the diagnosis and treatment of cardiac arrhythmias through advanced electrophysiology tools. Their innovative approach aims to enhance the precision and effectiveness of heart treatments, ultimately benefiting millions of patients worldwide.

Keywords: Cardiac, Electrophysiology, Arrhythmia, Medical Device, Innovation, Hospitals, Ablation, Intracardiac Electrograms, Horizon 2020, Healthcare.

Talent graph

CathVision's talent

Book a demo to see the people
Team profiled 10 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 2 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Investors

5 investors on CathVision's cap table

Sourced from Dealroom's funding history.

Seed 4 investors entered at this stage
Market Maturation Fund
Borean Innovation
Innovation Fund Denmark
European Commission
Series B+ 1 investor entered at this stage
Nordic Secondary Fund

Global footprint

Where CathVision has talent and traffic

Workforce by country
8 countries with
team presence
🇩🇰 Denmark59.4%
🇺🇸 United States15.6%
🇨🇭 Switzerland6.3%
🇵🇱 Poland6.3%
🇧🇪 Belgium3.1%
Top 5 of 8 shown

Market sentiment

What the market is saying about CathVision

An AI-synthesized read of the highest-engagement posts about CathVision on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See CathVision on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.